| Literature DB >> 8447116 |
S Arrighi1, L Pacenti, M G Borri.
Abstract
This study was carried out with the aim of developing a production process for the manufacture of a highly purified factor VIII concentrate which is virus inactivated by pasteurization in liquid phase. Beside standard plasma protein separation techniques, the procedure uses a chromatographic step on anion exchanger, whose selectivity is increased by using high, but not destabilizing salt concentrations. The final product before stabilization has a specific activity higher than 300 IU/mg of protein, namely the highest specific activity reported for human factor VIII concentrates purified without the use of immunoadsorbents.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8447116 DOI: 10.1111/j.1423-0410.1993.tb02508.x
Source DB: PubMed Journal: Vox Sang ISSN: 0042-9007 Impact factor: 2.144